Cory David A 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Feb 6, 2019
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2019-02-04$14.13/sh+227$3,208→ 58,678 total
Holdings
- 30,123(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.